VNDA Competitors
Vanda Pharmaceuticals Inc.
$4.20
+$0.11(+2.69%)
40
Overall
60
Value
27
Tech
34
Quality
Market Cap
$247.29M
Volume
643.76K
52W Range
$4.00 - $9.94
Target Price
$11.75
VNDA competitors: NVS, LLY, JNJ, BMY, PFE. Vanda Pharmaceuticals Inc. is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.
VNDA Competitors Compared
| Company | Price | Market cap | EPS est. (current yr) | Dividend yield | MarketXLS Rank |
|---|---|---|---|---|---|
| NVS Novartis AG | $150.20 | $286.60B | $8.91 | 3.18% | 70 |
| LLY Eli Lilly and Company | $1240.34 | $1.17T | $33.56 | 0.54% | 66 |
| JNJ Johnson & Johnson | $259.20 | $611.61B | $11.12 | 2.04% | 46 |
| BMY Bristol-Myers Squibb Company | $58.83 | $120.17B | $6.56 | 4.28% | 60 |
| PFE Pfizer Inc. | $29.44 | $167.80B | $2.95 | 5.84% | 70 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VNDA | $4.20 | +2.7% | 643.76K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Vanda Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW